NPPA Panel Defers Decision on Separate Price Cap for Cementless Knee Implants Written By Susmita Roy18 Feb 2026 11:57 PM ISTNew Delhi: The Multidisciplinary Committee (MDC) has decided to undertake further deliberations on requests from knee implant manufacturers and...
DTAB Sub-Panel to Reassess 29 'Irrational' FDCs Flagged by Kokate Committee: Report Written By Susmita Roy17 Feb 2026 11:00 PM ISTNew Delhi: In a major move to strengthen drug safety and rational prescribing practices, regulators have initiated a renewed examination of 29...
Mumbai: 180 super-speciality doctors demand job regularisation and pay revision Written By Annapurna17 Feb 2026 5:00 PM ISTMumbai: 180 super-speciality doctors working in Mumbai's municipal peripheral hospitals have gone without a single salary increment for five years....
Govt Reaffirms NPPA Stent Price Caps, States Tasked With Curbing Hospital Overcharging Written By Parthika Patel16 Feb 2026 4:33 PM ISTNew Delhi: The Government has clarified that coronary stents are under price control and private hospitals are required to comply with the notified...
DoP Issues Draft Revised List of 354 Medical Devices Exempt from Global Procurement, Invites Stakeholder Input Written By Susmita Roy15 Feb 2026 2:52 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, Government of India, has issued a public notice inviting...
Natco Pharma's Generic Semaglutide to Hit Indian Market in March Written By Parthika Patel14 Feb 2026 9:26 PM ISTNew Delhi: Natco Pharma Limited has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market...
Pharma Companies Told to Cut Prices of 17 Duty Exempt Cancer Drugs Written By Susmita Roy13 Feb 2026 8:41 PM ISTNew Delhi: In a follow-up to the customs duty relief on essential medicines, the National Pharmaceutical Pricing Authority (NPPA) has directed...
Over 200 Human and Veterinary Drugs Banned Since 2023, Parliament Told Written By Susmita Roy12 Feb 2026 7:30 PM ISTNew Delhi: The central government intensified regulatory action against unsafe medicines, banning 172 drugs meant for human use and 39 veterinary...
Health Ministry Moves to Simplify Ethics Committee Registration Under NDCT Rules Written By Susmita Roy11 Feb 2026 7:54 PM ISTNew Delhi: The Central Government has proposed amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019, seeking to remove the requirement...
CDSCO Clears AstraZeneca's Imfinzi (Durvalumab) for Additional Cancer Indication in India Written By Farhat Nasim10 Feb 2026 8:10 PM ISTNew Delhi: AstraZeneca Pharma India Ltd on Tuesday said it has received permission from India's drug regulator to market Durvalumab solution for...
Pharma Stalwarts Join Hands to Launch the Story of Desh Bandhu Gupta, Founder of Lupin Written By sheeba farhat9 Feb 2026 7:49 PM ISTMumbai: Made in India, authored by journalist Sundeep Khanna and TeamLease Services co-founder Manish Sabharwal, traces three interlinked journeys,...
Pharma Firms May Need Prior Approval for Major Drug Changes Under NDCT Draft Amendment Written By Susmita Roy8 Feb 2026 5:00 PM ISTNew Delhi: The Ministry of Health and Family Welfare (MoHFW), Department of Health and Family Welfare, has issued a draft notification proposing...
